Cerebral Vasospasm After Subarachnoid Hemorrhage: Respective Short-Term Effects of Induced Arterial Hypertension and its Combination With IV Milrinone: A Proof-of-Concept Study Using Transcranial Doppler Ultrasound.

Critical Care Explorations Pub Date : 2023-09-14 eCollection Date: 2023-09-01 DOI:10.1097/CCE.0000000000000973
Karim Lakhal, Marion H Fresco, Antoine Hivert, Bertrand Rozec, Julien Cadiet
{"title":"Cerebral Vasospasm After Subarachnoid Hemorrhage: Respective Short-Term Effects of Induced Arterial Hypertension and its Combination With IV Milrinone: A Proof-of-Concept Study Using Transcranial Doppler Ultrasound.","authors":"Karim Lakhal,&nbsp;Marion H Fresco,&nbsp;Antoine Hivert,&nbsp;Bertrand Rozec,&nbsp;Julien Cadiet","doi":"10.1097/CCE.0000000000000973","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>It is unclear whether IV milrinone relaxes spasmed cerebral arteries and therefore reduces cerebral blood mean velocity (V<sub>mean</sub>). In patients treated for cerebral vasospasm, we aimed to assess and delineate the respective impacts of induced hypertension and its combination with IV milrinone on cerebral hemodynamics as assessed with transcranial Doppler.</p><p><strong>Design: </strong>Observational proof-of-concept prospective study.</p><p><strong>Setting: </strong>ICU in a French tertiary care center.</p><p><strong>Patients: </strong>Patients with aneurysmal subarachnoid hemorrhage who received induced hypertension (mean arterial blood pressure [MBP] of 100-120 mm Hg) and IV milrinone (0.5 µg/kg/min) for moderate-to-severe cerebral vasospasm. We excluded patients who underwent invasive angioplasty or milrinone discontinuation within 12 hours after the diagnosis of vasospasm.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>V<sub>mean</sub> was measured at vasospasm diagnosis (T<sub>DIAGNOSIS</sub>), after the induction of hypertension (T<sub>HTN</sub>), and 1 (T<sub>HTN+MILRINONE_H1</sub>) and 12 hours after the adjunction of IV milrinone (T<sub>HTN+MILRINONE_H12</sub>). Thirteen patients were included. Median V<sub>mean</sub> was significantly lower (<i>p</i> < 0.01) at T<sub>HTN+MILRINONE_H1</sub> (99 [interquartile range (IQR) 89; 134] cm.s<sup>-1</sup>) and T<sub>HTN+MILRINONE_H12</sub> (85 [IQR 73-127] cm/s) than at T<sub>DIAGNOSIS</sub> (136 [IQR 115-164] cm/s) and T<sub>HTN</sub> (148 [IQR 115-183] cm/s), whereas T<sub>DIAGNOSIS</sub> and T<sub>HTN</sub> did not significantly differ. In all patients but one, V<sub>mean</sub> at T<sub>HTN+MILRINONE_H1</sub> was lower than its value at T<sub>DIAGNOSIS</sub> (<i>p</i> = 0.0005). V<sub>mean</sub>-to-MBP and V<sub>mean</sub>-to-cardiac output (CO) ratios (an assessment of V<sub>mean</sub> regardless of the level of MBP [<i>n</i> = 13] or CO [<i>n</i> = 7], respectively) were, respectively, similar at T<sub>DIAGNOSIS</sub> and T<sub>HTN</sub> but were significantly lower after the adjunction of milrinone (<i>p</i> < 0.01).</p><p><strong>Conclusions: </strong>The induction of arterial hypertension was not associated with a significant decrease in V<sub>mean</sub>, whereas the adjunction of IV milrinone was, regardless of the level of MBP or CO. This suggests that IV milrinone may succeed in relaxing spasmed arteries.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 9","pages":"e0973"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/0e/cc9-5-e0973.PMC10503695.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000000973","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: It is unclear whether IV milrinone relaxes spasmed cerebral arteries and therefore reduces cerebral blood mean velocity (Vmean). In patients treated for cerebral vasospasm, we aimed to assess and delineate the respective impacts of induced hypertension and its combination with IV milrinone on cerebral hemodynamics as assessed with transcranial Doppler.

Design: Observational proof-of-concept prospective study.

Setting: ICU in a French tertiary care center.

Patients: Patients with aneurysmal subarachnoid hemorrhage who received induced hypertension (mean arterial blood pressure [MBP] of 100-120 mm Hg) and IV milrinone (0.5 µg/kg/min) for moderate-to-severe cerebral vasospasm. We excluded patients who underwent invasive angioplasty or milrinone discontinuation within 12 hours after the diagnosis of vasospasm.

Interventions: None.

Measurements and main results: Vmean was measured at vasospasm diagnosis (TDIAGNOSIS), after the induction of hypertension (THTN), and 1 (THTN+MILRINONE_H1) and 12 hours after the adjunction of IV milrinone (THTN+MILRINONE_H12). Thirteen patients were included. Median Vmean was significantly lower (p < 0.01) at THTN+MILRINONE_H1 (99 [interquartile range (IQR) 89; 134] cm.s-1) and THTN+MILRINONE_H12 (85 [IQR 73-127] cm/s) than at TDIAGNOSIS (136 [IQR 115-164] cm/s) and THTN (148 [IQR 115-183] cm/s), whereas TDIAGNOSIS and THTN did not significantly differ. In all patients but one, Vmean at THTN+MILRINONE_H1 was lower than its value at TDIAGNOSIS (p = 0.0005). Vmean-to-MBP and Vmean-to-cardiac output (CO) ratios (an assessment of Vmean regardless of the level of MBP [n = 13] or CO [n = 7], respectively) were, respectively, similar at TDIAGNOSIS and THTN but were significantly lower after the adjunction of milrinone (p < 0.01).

Conclusions: The induction of arterial hypertension was not associated with a significant decrease in Vmean, whereas the adjunction of IV milrinone was, regardless of the level of MBP or CO. This suggests that IV milrinone may succeed in relaxing spasmed arteries.

蛛网膜下腔出血后的脑血管痉挛:诱导性动脉高压及其与静脉注射米力农联合应用的短期效应:经颅多普勒超声概念验证研究。
目的:目前尚不清楚静脉注射米力农是否能放松痉挛的脑动脉,从而降低脑血平均流速(Vmean)。在接受脑血管痉挛治疗的患者中,我们旨在评估和描述经颅多普勒评估的诱导性高血压及其与静脉注射米力农联合用药对脑血流动力学的影响。设计:观察性概念验证前瞻性研究。环境:法国三级护理中心的重症监护室。患者:接受诱导性高血压治疗的动脉瘤性蛛网膜下腔出血患者(平均动脉血压[MBP]为100-120 毫米汞柱)和静脉注射米力农(0.5µg/kg/min)治疗中度至重度脑血管痉挛。我们排除了在诊断为血管痉挛后12小时内接受侵入性血管成形术或停用米力农的患者。干预措施:无。测量和主要结果:在血管痉挛诊断(TDIAGNOSIS)、高血压诱导(THTN)后、静脉滴注米力农(THTN+MILRINONE_H1)1小时和12小时后测量Vmean。包括13名患者。THTN+MILRINONE_H1(99[四分位间距(IQR)89;134]cm/s-1)和THTN+MILRINONE_H12(85[IQR 73-127]cm/s)的中值Vmean显著低于TDIAGNOSIS(136[IQR 115-164]cm/s)和THTN(148[IQR 115-183]cm/s),而TDIAGNOS和THTN没有显著差异。在除一名患者外的所有患者中,THTN+MILRINONE_H1的Vmean均低于TDIAGNOSIS的值(p=0.0005),TDIAGNOSIS和THTN相似,但在添加米力农后显著降低(p<0.01)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信